Skip to content

Evaluation of chemotherapy induced small intestinal injury by capsule endoscopy

Evaluation of chemotherapy induced small intestinal injury by capsule endoscopy - Evaluation of chemothelapy induced small intestinal injury by capsule endoscopy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000014909
Enrollment
30
Registered
2014-09-01
Start date
2014-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Cancer/Gastric Cancer/Colorectal Cancer

Interventions

capsule endoscopy

Sponsors

Osaka Medical College
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The subjects who agree to participate in this study by written informed consent. 2. The subject who receive chemothetapy. 3. The subject who received patency capsule endoscopy and are proved patency of gastrointestinal tract.

Exclusion criteria

Exclusion criteria: 1. Dysphagia 2. Poor general cindition. 3. The subjects who can not prove patency of gastrointestinal tract. 4. The subject with allergic reaction barium examination. 5. The subject who have a pacemaker and other medical equipment. 6. The subject who do not agree agreement for surgical removal of 7. The patient who participates in another study which may affect this study. 8. The subject who are judged to be inappropriate for this study by doctors conducting this study.

Design outcomes

Primary

MeasureTime frame
Evaluation of the small intestinal injuries induced by chemothelapy

Secondary

MeasureTime frame
1.Location and From of small intestinal injuries. 2.We compare the change of Plasma diamioxidase(DAO) activities and calprotectin before and after chemotherapy. 3.We check a correlation with Lewis score in DAO and calprotectin

Countries

Japan

Contacts

Public ContactMunetaka Iguchi

Osaka Medical College Second Dep of Internal Medicine

mune.iguchi@gmail.com072-683-1221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026